Clinical Trial Details


Research Study Summary

A multicenter, double blind, randomized, parallel group, placebo controlled study to assess the clinical effect of Droxidopa in the treatment of symptomatic neurogenic orthostatis hypotension in patients with Parkinson's Disease


The purpose of this research study is to determine whether Droxidopa can relieve the symptoms of NOH and whether it causes any side effects in people with symptomatic NOH. Droxidopa is a drug that is changed in the body to a chemical called norepinephrine. Norepinephrine is a chemical in your body that is used by your body’s nervous system to signal nerves that control blood pressure. The study drug that you will take if you are in this study is a capsule that contains either Droxidopa or placebo (an identical-looking pill that does not contain any active drug; a placebo is sometimes called a "sugar pill"). The reason for having people take placebo in this study is to see if taking droxidopa is better than taking placebo.

Please contact Alexian Brothers for more information on participation.

To Learn more

CW ID: 176859
Date Last Changed: July 22, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


Alexian Brothers Hospital Network
800 Biesterfield Road Brock Building First Floor
Elk Grove Village, IL 60007
Phone: 847-593-8553

View Map

Research Center Information:

Alexian Brothers Hospital Network

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.